Infusive US Trust - Infusive Compounding Global Equities ETF's receivables is $170M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for JOYY is $170M as of June 2026. That compares with $130M in the prior-year period — up 28.0% year over year. Investors often review this figure alongside Infusive US Trust - Infusive Compounding Global Equities ETF's historical trend and sector peers before judging valuation or financial health.
Over the past year, JOYY's receivables moved from $130M to $170M — a 28.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Infusive US Trust - Infusive Compounding Global Equities ETF's operating scale or balance-sheet position.
A receivables figure of $170M for JOYY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting JOYY's receivables ($170M), review year-over-year change from $130M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.